The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ajjarapu Surendra K since 2018.
This trader's CIK number is 1368298.
At the time of last reporting, Ajjarapu Surendra K was the CEO of Trxade Health, Inc. (stock ticker symbol MEDS).
Also see all insider trading activities at Trxade Health, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | MEDS | 10,000 | $130,000,000 | 0 | $0 | 0 | $0 |
| 2017 | MEDS | 0 | $0 | 250,000 | $28,125,000,000 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-20 | MEDS | Buy | 10,000 | 13,000.00 | 130,000,000 |
| 2017-11-15 | TRXD | Sale | 250,000 | 112,500.00 | 28,125,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ajjarapu Surendra K (CEO of Trxade Health, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.